Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Ann H. Partridge, MD, MPH


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Vice Chair of Medical Oncology
  • Founder and Director, Program for Young Women with Breast Cancer
  • Director, Adult Survivorship Program
  • Senior Physician
  • Professor of Medicine, Harvard Medical School

Clinical Interests

  • Breast cancer in young women

Diseases Treated

Contact Information

  • Appointments617-632-2175 (new)
    617-632-3800 (follow-up)
  • Office Phone Number617-632-3800
  • Fax617-632-1930

Bio

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI. Later she received an MPH from Harvard School of Public Health. She is a medical oncologist focusing on the care of women with breast cancer, and she has a particular interest in the psychosocial, behavioral, and communication issues in breast cancer care and treatment.

Board Certification:

  • Hematology, 2001
  • Internal Medicine, 1998
  • Medical Oncology, 2001

Fellowship:

  • Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency:

  • University of Pennsylvania School of Medicine, Internal Medicine

Medical School:

  • Weill Medical College of Cornell University

Research

Clinical and Epidemiologic Research in Breast Cancer

Breast cancer is the most common malignancy in U.S. women, with over 215,000 new cases diagnosed in 2005. Although the median age at breast cancer diagnosis is approximately 65, more than 14,000 women 40 years of age or younger are diagnosed with breast cancer each year in the United States. Because women in this younger age group represent a minority of the women diagnosed with breast cancer, far less is known about breast cancer in younger women than older women. Evidence shows that young age is an independent risk factor for disease recurrence and death. It is controversial whether the poorer prognosis is a reflection of delays in diagnosis or differences in biology, but accumulating evidence indicates that biologic differences may play an important role. In addition to being at higher risk of dying from breast cancer than older women, young women with breast cancer are at increased risk of psychosocial distress at diagnosis and in follow-up when compared with older women. Young women with breast cancer face a variety of unique medical and psychosocial concerns as a result of their diagnosis and subsequent treatment. In particular, fertility and family planning, menopausal symptoms, and sexual functioning are of great concern to this patient population. Our research focuses on the psychosocial, behavioral, and communication issues associated with breast cancer care, especially the unique issues facing young women with breast cancer. Several ongoing projects include evaluation of adherence with hormonal therapies in women with early-stage breast cancer, assessment of fertility and fertility concerns in young women undergoing breast cancer treatment, and communication of study results to patients following clinical trial participation.

Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation. J Natl Cancer Inst. 2021 May 28.
View in: PubMed

ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 May 15.
View in: PubMed

Optimizing Decision Making for Ductal Carcinoma in Situ: Facts Over Fear. J Natl Cancer Inst. 2021 May 04; 113(5):511-512.
View in: PubMed

Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 2021 Apr 22.
View in: PubMed

Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol. 2021 Apr 21.
View in: PubMed

Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 2021 Apr 20.
View in: PubMed

Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. Oncologist. 2021 Apr 15.
View in: PubMed

Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance). JNCI Cancer Spectr. 2021 Jun; 5(3):pkab025.
View in: PubMed

Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy. J Natl Cancer Inst. 2021 Apr 06; 113(4):443-452.
View in: PubMed

Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 Apr 05.
View in: PubMed

Cyclophosphamide-free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women with Breast Cancer. J Natl Cancer Inst. 2021 Apr 02.
View in: PubMed

Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer. Cancer Chemother Pharmacol. 2021 May; 87(5):673-679.
View in: PubMed

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ Breast Cancer. 2021 Feb 12; 7(1):16.
View in: PubMed

A new look at old problems: Ovarian function suppression in the real world. Cancer. 2021 Apr 15; 127(8):1174-1176.
View in: PubMed

Surgical Treatment after Neoadjuvant Systemic Therapy in Young Women with Breast Cancer: Results from a Prospective Cohort Study. Ann Surg. 2020 Dec 23; Publish Ahead of Print.
View in: PubMed

Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. Cancer. 2021 Apr 01; 127(7):1021-1028.
View in: PubMed

Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Res Treat. 2021 Apr; 186(3):815-821.
View in: PubMed

Anti-mullerian hormone as a serum biomarker for risk of chemotherapy-induced amenorrhea. J Natl Cancer Inst. 2020 Nov 07.
View in: PubMed

Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2021 Feb; 186(1):157-165.
View in: PubMed

Body weight and return to work among survivors of early-stage breast cancer. ESMO Open. 2020 11; 5(6):e000908.
View in: PubMed

Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors. JAMA Surg. 2020 11 01; 155(11):1035-1042.
View in: PubMed

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial. JAMA. 2020 10 13; 324(14):1406-1418.
View in: PubMed

Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial. BMC Public Health. 2020 Oct 06; 20(1):1514.
View in: PubMed

Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health. J Psychosoc Oncol. 2020 Nov-Dec; 38(6):670-686.
View in: PubMed

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2020 10 01; 6(10):1598-1605.
View in: PubMed

Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):315-322.
View in: PubMed

The utility of magnetic resonance imaging in early-stage breast cancer survivors-An institutional experience and literature review. Breast J. 2020 09; 26(9):1673-1679.
View in: PubMed

Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. J Clin Oncol. 2020 09 10; 38(26):3012-3023.
View in: PubMed

Posttraumatic stress in breast cancer survivors diagnosed at a young age. Psychooncology. 2020 08; 29(8):1312-1320.
View in: PubMed

Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab. Clin Cancer Res. 2020 09 15; 26(18):4911-4920.
View in: PubMed

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk. J Clin Oncol. 2020 08 20; 38(24):2762-2772.
View in: PubMed

Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial. Breast. 2020 Oct; 53:1-7.
View in: PubMed

Hodgkin Lymphoma Survivor Wellness: Development of a Web-Based Intervention. Clin J Oncol Nurs. 2020 06 01; 24(3):284-289.
View in: PubMed

Prediction of Breast Cancer Treatment-Induced Fatigue by Machine Learning Using Genome-Wide Association Data. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa039.
View in: PubMed

Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review. J Natl Cancer Inst. 2020 05 01; 112(5):443-465.
View in: PubMed

Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study. Breast. 2020 Aug; 52:23-32.
View in: PubMed

ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. 2020 06; 31(6):674-696.
View in: PubMed

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020 06 01; 26(11):2556-2564.
View in: PubMed

Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients. PLoS One. 2020; 15(3):e0230529.
View in: PubMed

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019 Nov; 30(11):1784-1795.
View in: PubMed

Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. J Clin Oncol. 2020 03 01; 38(7):725-733.
View in: PubMed

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012 Dec; 23(12):3075-3081.
View in: PubMed

Clinical Benefit in the Treatment of Patients with Early Breast Cancer. Breast. 2019 Nov; 48 Suppl 1:S115-S118.
View in: PubMed

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019 11 01; 30(11):1784-1795.
View in: PubMed

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. Oncologist. 2020 04; 25(4):310-318.
View in: PubMed

Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. Oncologist. 2019 Oct 14.
View in: PubMed

Aggressive Subsets of Metastatic Triple Negative Breast Cancer. Clin Breast Cancer. 2020 02; 20(1):e20-e26.
View in: PubMed

Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. Fertil Steril. 2019 10; 112(4):731-739.e1.
View in: PubMed

Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients. Med Decis Making. 2019 08; 39(6):642-650.
View in: PubMed

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348.
View in: PubMed

Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer. Breast J. 2019 11; 25(6):1104-1110.
View in: PubMed

Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. Breast. 2019 Oct; 47:85-92.
View in: PubMed

Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2019 08 20; 37(24):2120-2130.
View in: PubMed

Employment trends in young women following a breast cancer diagnosis. Breast Cancer Res Treat. 2019 Aug; 177(1):207-214.
View in: PubMed

Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. PLoS One. 2019; 14(5):e0216997.
View in: PubMed

Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer. Cancer. 2019 09 15; 125(18):3266-3274.
View in: PubMed

Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Res Treat. 2019 Jul; 176(2):303-310.
View in: PubMed

Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ. Mod Pathol. 2019 09; 32(9):1257-1262.
View in: PubMed

Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz008.
View in: PubMed

Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. J Adolesc Young Adult Oncol. 2019 08; 8(4):463-468.
View in: PubMed

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. J Clin Oncol. 2019 08 01; 37(22):1868-1875.
View in: PubMed

Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233.
View in: PubMed

Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning. Psychooncology. 2019 05; 28(5):1033-1040.
View in: PubMed

Fatigue and physical activity in cancer survivors: A cross-sectional population-based study. Cancer Med. 2019 05; 8(5):2535-2544.
View in: PubMed

Amenorrhea after lung cancer treatment. Menopause. 2019 03; 26(3):306-310.
View in: PubMed

Reproductive Health Issues for Young Women with Breast Cancer: Emerging Strategies for Difficult Situations. Ann Surg Oncol. 2019 May; 26(5):1170-1172.
View in: PubMed

A randomized study to improve care for young women with breast cancer at community and academic medical oncology practices in the United States: The Young and Strong study. Cancer. 2019 06 01; 125(11):1799-1806.
View in: PubMed

Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. J Natl Cancer Inst. 2019 02 01; 111(2):210-213.
View in: PubMed

Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients. Reprod Biomed Online. 2019 May; 38(5):835-844.
View in: PubMed

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063.
View in: PubMed

Case-control study of heart rate abnormalities across the breast cancer survivorship continuum. Cancer Med. 2019 01; 8(1):447-454.
View in: PubMed

Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev. 2019 Jan; 72:65-77.
View in: PubMed

Reply to V. Turan et al. J Clin Oncol. 2019 01 01; 37(1):86-88.
View in: PubMed

Pregnancy after cancer: Timing is everything. Cancer. 2018 11 15; 124(22):4290-4291.
View in: PubMed

Open-label placebo reduces fatigue in cancer survivors: a randomized trial. Support Care Cancer. 2019 Jun; 27(6):2179-2187.
View in: PubMed

Pregnancy-Associated Cancer: A U.S. Population-Based Study. J Womens Health (Larchmt). 2019 02; 28(2):250-257.
View in: PubMed

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153.
View in: PubMed

The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. Breast. 2018 Dec; 42:41-49.
View in: PubMed

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018 06; 25(6):596-608.
View in: PubMed

Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PLoS One. 2018; 13(5):e0197931.
View in: PubMed

Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 08 10; 36(23):2433-2443.
View in: PubMed

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018 07 01; 36(19):1981-1990.
View in: PubMed

Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Ovarian Ablation Is a Viable Option for Select Patients. Oncology (Williston Park). 2018 04 15; 32(4):168, 171, 179.
View in: PubMed

"I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology. 2018 06; 27(6):1524-1529.
View in: PubMed

Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018 07 01; 36(19):1994-2001.
View in: PubMed

The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 05; 9(3):221-227.
View in: PubMed

Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. Psychosomatics. 2018 May - Jun; 59(3):251-258.
View in: PubMed

Exogenous reproductive hormone use in breast cancer survivors and previvors. Nat Rev Clin Oncol. 2018 04; 15(4):249-261.
View in: PubMed

Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 03 01; 36(7):682-688.
View in: PubMed

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2018 02 20; 36(6):543-553.
View in: PubMed

Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. 2018 01 01; 29(1):281-282.
View in: PubMed

Randomized trial of a clinic-based weight loss intervention in cancer survivors. J Cancer Surviv. 2018 04; 12(2):186-195.
View in: PubMed

ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017 Oct; 35:203-217.
View in: PubMed

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials. Ann Surg Oncol. 2017 Nov; 24(12):3534-3540.
View in: PubMed

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 08 01; 28(8):1700-1712.
View in: PubMed

Risk communication and decision-making in the prevention of invasive breast cancer. Breast. 2017 Aug; 34 Suppl 1:S55-S57.
View in: PubMed

Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. J Adolesc Young Adult Oncol. 2017 Sep; 6(3):429-434.
View in: PubMed

Ovarian Suppression for Women Younger Than 35 Years: New Data to Support Informed Decision Making. J Clin Oncol. 2017 09 20; 35(27):3092-3094.
View in: PubMed

Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy? Breast Cancer Res Treat. 2017 Oct; 165(3):545-553.
View in: PubMed

Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer. Clin Cancer Res. 2017 Jun 01; 23(11):2647-2654.
View in: PubMed

Unmet Needs in Clinical Research in Breast Cancer: Where Do We Need to Go? Clin Cancer Res. 2017 Jun 01; 23(11):2611-2616.
View in: PubMed

A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2017 May 01; 3(5):677-685.
View in: PubMed

Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values. Oncologist. 2017 07; 22(7):860-863.
View in: PubMed

Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer. 2017 Aug 01; 123(15):2821-2828.
View in: PubMed

Fertility concerns among breast cancer patients in Mexico. Breast. 2017 Jun; 33:71-75.
View in: PubMed

Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. JAMA Oncol. 2017 Mar 01; 3(3):402-409.
View in: PubMed

Research needs in breast cancer. Ann Oncol. 2017 02 01; 28(2):208-217.
View in: PubMed

Reply to L. Del Mastro and A. Prat. J Clin Oncol. 2017 04 01; 35(10):1139.
View in: PubMed

Looking back, moving forward: the evolution of cancer survivorship care. Lancet Oncol. 2017 01; 18(1):18-19.
View in: PubMed

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. J Clin Oncol. 2017 Feb; 35(4):421-431.
View in: PubMed

Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017 02; 7(2):202-217.
View in: PubMed

The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 2017 02; 7(2):177-187.
View in: PubMed

Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer. 2017 Apr 01; 123(7):1249-1258.
View in: PubMed

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373.
View in: PubMed

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016 12; 160(3):393-410.
View in: PubMed

Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017 02; 11(1):74-79.
View in: PubMed

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. J Clin Oncol. 2016 09 20; 34(27):3308-14.
View in: PubMed

Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016 Nov 15; 122(22):3546-3554.
View in: PubMed

Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016 08; 159(1):109-18.
View in: PubMed

Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):243-51.
View in: PubMed

A pilot videoconference group stress management program in cancer survivors: lessons learned. Rural Remote Health. 2016 Apr-Jun; 16(2):3863.
View in: PubMed

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6.
View in: PubMed

Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. Oncologist. 2016 06; 21(6):666-70.
View in: PubMed

Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol. 2016 07 10; 34(20):2416-27.
View in: PubMed

Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety. J Natl Compr Canc Netw. 2016 03; 14(3):355-63.
View in: PubMed

A pilot trial of brief group cognitive-behavioral treatment for insomnia in an adult cancer survivorship program. Psychooncology. 2017 06; 26(6):843-848.
View in: PubMed

Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016 Apr 15; 122(8):1169-77.
View in: PubMed

Second international consensus guidelines for breast cancer in young women (BCY2). Breast. 2016 Apr; 26:87-99.
View in: PubMed

Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016 Jan 04; 14:1.
View in: PubMed

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics. J Clin Oncol. 2016 Feb 20; 34(6):539-41.
View in: PubMed

Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2016 Mar; 5(1):16-23.
View in: PubMed

Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results. JAMA. 2015 Dec 22-29; 314(24):2625-7.
View in: PubMed

Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics. Patient Prefer Adherence. 2015; 9:1587-92.
View in: PubMed

Management of breast cancer in very young women. Breast. 2015 Nov; 24 Suppl 2:S154-8.
View in: PubMed

Chemotherapy in Premenopausal Breast Cancer Patients. Breast Care (Basel). 2015 Oct; 10(5):307-10.
View in: PubMed

Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: An analysis of four alliance clinical trials. J Clin Oncol. 2015 Oct; 33(28_suppl):33.
View in: PubMed

Breast Cancer in Young Women: Rare Disease or Public Health Problem? JAMA Oncol. 2015 Oct; 1(7):877-8.
View in: PubMed

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015 Dec; 26(12):2408-19.
View in: PubMed

A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. J Community Support Oncol. 2015 Sep; 13(9):323-9.
View in: PubMed

Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. Clin Breast Cancer. 2016 Apr; 16(2):105-12.
View in: PubMed

New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. J Natl Cancer Inst. 2015 Oct; 107(10).
View in: PubMed

Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol. 2015 Oct; 22(10):3219-24.
View in: PubMed

More Options for Premenopausal Women With Early-Stage Hormone-Sensitive Breast Cancer. Oncology (Williston Park). 2015 Jul; 29(7):482, 492.
View in: PubMed

Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. JAMA Oncol. 2015 Jun; 1(3):369-74.
View in: PubMed

Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist. 2015 Jul; 20(7):713-8.
View in: PubMed

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Breast Cancer Res Treat. 2015 Jun; 151(3):589-96.
View in: PubMed

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. J Clin Oncol. 2015 Jul 10; 33(20):2254-61.
View in: PubMed

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov; 22(12):3809-15.
View in: PubMed

Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist. 2015 Jun; 20(6):598-604.
View in: PubMed

Partner support and anxiety in young women with breast cancer. Psychooncology. 2015 Dec; 24(12):1679-85.
View in: PubMed

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 03 05; 372(10):923-32.
View in: PubMed

Reply to C. Twelves et Al. J Clin Oncol. 2015 Apr 10; 33(11):1301.
View in: PubMed

Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting. J Adolesc Young Adult Oncol. 2015 Mar; 4(1):34-43.
View in: PubMed

Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Oncol Pract. 2015 Mar; 11(2):e222-9.
View in: PubMed

Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? Breast. 2015 Jun; 24(3):201-7.
View in: PubMed

Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015 Feb; 27(1):98-107.
View in: PubMed

Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health. 2015 Jan 31; 15:37.
View in: PubMed

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015 Jan 08; 372(2):134-41.
View in: PubMed

Challenges to Standardizing the Care for Adult Cancer Survivors: Highlighting ASCO's Fatigue and Anxiety and Depression Guidelines. Am Soc Clin Oncol Educ Book. 2015; 188-94.
View in: PubMed

Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2015 Jan; 11(1):42-3.
View in: PubMed

Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. J Oncol Pract. 2015 01; 11(1):6-11.
View in: PubMed

ABCDE steps to prevent heart disease in breast cancer survivors. Circulation. 2014 Oct 28; 130(18):e157-9.
View in: PubMed

Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. J Community Support Oncol. 2014 Oct; 12(10):347-54.
View in: PubMed

Developing a service model that integrates palliative care throughout cancer care: the time is now. J Clin Oncol. 2014 Oct 10; 32(29):3330-6.
View in: PubMed

Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014 Oct 10; 32(29):3307-29.
View in: PubMed

Biology of breast cancer in young women. Breast Cancer Res. 2014 Aug 27; 16(4):427.
View in: PubMed

The relationship between the belief in a genetic cause for breast cancer and bilateral mastectomy. Health Psychol. 2015 May; 34(5):473-6.
View in: PubMed

The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 2014 Jul 12; 14:513.
View in: PubMed

Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). J Clin Oncol. 2014 Jun 20; 32(18_suppl):LBA505.
View in: PubMed

Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist. 2014 Aug; 19(8):814-22.
View in: PubMed

Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen. Clin Breast Cancer. 2014 Dec; 14(6):413-6.
View in: PubMed

Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making. JAMA Surg. 2014 Jun; 149(6):589-90.
View in: PubMed

Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer. 2014 Aug 01; 120(15):2264-71.
View in: PubMed

Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat. 2014 Jun; 145(2):525-34.
View in: PubMed

First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014 Jun; 23(3):209-20.
View in: PubMed

Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014 Aug; 21(8):2506-11.
View in: PubMed

Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014 May 20; 32(15):1605-19.
View in: PubMed

Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014 Apr; 144(3):591-7.
View in: PubMed

Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014 Apr 10; 32(11):1151-6.
View in: PubMed

Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014 Jan 20; 32(3):199-205.
View in: PubMed

Reply to D. Serraino et al. J Clin Oncol. 2014 Jan 10; 32(2):161.
View in: PubMed

Young Women with Breast Cancer: A Focus Group Study of Unmet Needs. J Adolesc Young Adult Oncol. 2013 Dec 01; 2(4):153-160.
View in: PubMed

Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013 Dec; 40(6):804-12.
View in: PubMed

Breast cancer presentation and diagnostic delays in young women. Cancer. 2014 Jan 01; 120(1):20-5.
View in: PubMed

Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat. 2013 Nov; 142(1):165-75.
View in: PubMed

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice. Breast Cancer Res Treat. 2013 Oct; 141(3):421-7.
View in: PubMed

Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013 Sep 17; 159(6):373-81.
View in: PubMed

Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):606-15.
View in: PubMed

Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):593-605.
View in: PubMed

Management of breast cancer in very young women. Breast. 2013 Aug; 22 Suppl 2:S176-9.
View in: PubMed

Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research. Breast Cancer Res Treat. 2013 Aug; 140(3):447-52.
View in: PubMed

Contemporary multidisciplinary treatment of pregnancy-associated breast cancer. Springerplus. 2013 Dec; 2(1):297.
View in: PubMed

Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol. 2013 Jul 20; 31(21):2692-8.
View in: PubMed

Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013 Jun; 5 Suppl 1:S55-61.
View in: PubMed

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 01; 31(19):2500-10.
View in: PubMed

Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol. 2013 Sep; 24(9):2224-35.
View in: PubMed

Predictors of recovery of ovarian function during aromatase inhibitor therapy. Ann Oncol. 2013 Aug; 24(8):2011-6.
View in: PubMed

Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist. 2013; 18(4):362-8.
View in: PubMed

High performance teamwork training and systems redesign in outpatient oncology. BMJ Qual Saf. 2013 May; 22(5):405-13.
View in: PubMed

Quality of life and symptoms in male breast cancer survivors. Breast. 2013 Apr; 22(2):197-199.
View in: PubMed

Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013; 18(8):e19-20.
View in: PubMed

Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol. 2013 Jan 01; 31(1):131-61.
View in: PubMed

Implementation of team training in outpatient breast oncology. J Clin Oncol. 2012 Dec; 30(34_suppl):83.
View in: PubMed

Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer. 2013 Jan 01; 119(1):158-63.
View in: PubMed

Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer. 2013 Jan 01; 119(1):164-72.
View in: PubMed

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat. 2012 Dec; 136(3):919-26.
View in: PubMed

Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013 Aug; 22(8):1849-55.
View in: PubMed

Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012 Dec; 136(3):813-21.
View in: PubMed

Fertility (male and female) and menopause. J Clin Oncol. 2012 Oct 20; 30(30):3705-11.
View in: PubMed

Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat. 2012 Oct; 135(3):893-906.
View in: PubMed

Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med. 2013 Feb; 10(2):370-7.
View in: PubMed

Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012 Dec; 23(12):3075-3081.
View in: PubMed

Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012 Jun 08; 12:51.
View in: PubMed

Model program to improve care for a unique cancer population: young women with breast cancer. J Oncol Pract. 2012 Sep; 8(5):e105-10.
View in: PubMed

The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012; 17(6):775-82.
View in: PubMed

Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin. 2012 May-Jun; 62(3):203-10.
View in: PubMed

Quality of life in long-term survivors of metastatic breast cancer. Clin Breast Cancer. 2012 Apr; 12(2):119-26.
View in: PubMed

Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates. Cancer. 2012 Oct 01; 118(19):4801-5.
View in: PubMed

Coping and psychological distress in young adults with advanced cancer. J Support Oncol. 2012 May-Jun; 10(3):124-30.
View in: PubMed

Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? J Clin Oncol. 2012 Feb 10; 30(5):479-81.
View in: PubMed

Clinical problem-solving. Breathless. N Engl J Med. 2012 Jan 05; 366(1):75-81.
View in: PubMed

The unique reproductive concerns of young women with breast cancer. Adv Exp Med Biol. 2012; 732:77-87.
View in: PubMed

Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril. 2012 Jan; 97(1):154-9.
View in: PubMed

Interactive medical case. Breathless. N Engl J Med. 2011 Dec 22; 365(25):e47.
View in: PubMed

Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol. 2012 Jan 10; 30(2):158-63.
View in: PubMed

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):1061-6.
View in: PubMed

Decision making about surgery for early-stage breast cancer. J Am Coll Surg. 2012 Jan; 214(1):1-10.
View in: PubMed

Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011 Nov; 7(6):398-401.
View in: PubMed

Adjuvant therapies for very young women with early stage breast cancer. Breast. 2011 Oct; 20 Suppl 3:S146-9.
View in: PubMed

Reproductive endocrinology: triptorelin ovarian suppression during breast cancer chemotherapy. Nat Rev Endocrinol. 2011 Sep 20; 7(11):637-8.
View in: PubMed

American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer. J Clin Oncol. 2011 Oct 10; 29(29):3939-42.
View in: PubMed

Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat. 2011 Sep; 129(2):309-17.
View in: PubMed

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases. Clin Breast Cancer. 2011 Dec; 11(6):376-83.
View in: PubMed

Patient perspectives on a treatment plan and summary program in community oncology care. J Clin Oncol. 2011 May 20; 29(15_suppl):6027.
View in: PubMed

Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. J Clin Oncol. 2011 May 20; 29(15_suppl):1000.
View in: PubMed

Understanding the psychosocial needs of young adults with cancer: Identifying targets for clinical intervention. J Clin Oncol. 2011 May 20; 29(15_suppl):9068.
View in: PubMed

Fertility concerns in young women with breast cancer: Results from a prospective cohort study. J Clin Oncol. 2011 May 20; 29(15_suppl):6025.
View in: PubMed

The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program. J Clin Oncol. 2011 May 20; 29(15_suppl):6101.
View in: PubMed

A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):559.
View in: PubMed

Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol. 2011 Mar 10; 29(8):1022-8.
View in: PubMed

Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article]. Plast Reconstr Surg. 2011 Jan; 127(1):18-26.
View in: PubMed

Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause. 2011 Jan; 18(1):105-8.
View in: PubMed

Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010 Sep-Oct; 17(5):908-16.
View in: PubMed

Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. J Womens Health (Larchmt). 2010 Aug; 19(8):1553-9.
View in: PubMed

Non-adherence: a new epidemic? Eur J Cancer. 2010 Jul; 46(10):1767.
View in: PubMed

Medication errors involving oral chemotherapy. Cancer. 2010 May 15; 116(10):2455-64.
View in: PubMed

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol. 2010 May 20; 28(15):2635-40.
View in: PubMed

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010 May 10; 28(14):2418-22.
View in: PubMed

The role of socioeconomic status in adjustment after ductal carcinoma in situ. Cancer. 2010 Mar 01; 116(5):1218-25.
View in: PubMed

The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. 2010 Feb 15; 116(4):791-8.
View in: PubMed

On mammography--more agreement than disagreement. N Engl J Med. 2009 Dec 24; 361(26):2499-501.
View in: PubMed

Genetic testing in young women with breast cancer: results from a Web-based survey. Ann Oncol. 2010 Apr; 21(4):741-747.
View in: PubMed

Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53.
View in: PubMed

Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making. J Clin Oncol. 2009 May 20; 27(15_suppl):572.
View in: PubMed

Presentation of breast cancer in young women. J Clin Oncol. 2009 May 20; 27(15_suppl):6608.
View in: PubMed

Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65.
View in: PubMed

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010 Jul; 94(2):638-44.
View in: PubMed

Breast cancer in young women: clinical decision-making in the face of uncertainty. Oncology (Williston Park). 2009 May; 23(6):474, 477.
View in: PubMed

Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82.
View in: PubMed

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat. 2009 Oct; 117(3):615-23.
View in: PubMed

Adherence with adjuvant hormonal therapy for breast cancer. Ann Oncol. 2009 Mar; 20(3):401-2.
View in: PubMed

Sharing study results with trial participants: time for action. J Clin Oncol. 2009 Feb 20; 27(6):838-9.
View in: PubMed

Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009 Jan-Feb; 59(1):56-66.
View in: PubMed

Optimizing endocrine therapy in premenopausal ER-positive breast cancer patients. Oncology (Williston Park). 2009 Jan; 23(1):34, 40.
View in: PubMed

Fertility. Cancer Treat Res. 2009; 151:367-85.
View in: PubMed

Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ. Ann Surg Oncol. 2009 Jan; 16(1):106-12.
View in: PubMed

Breast cancer in young women: a new color or a different shade of pink? J Clin Oncol. 2008 Jul 10; 26(20):3303-5.
View in: PubMed

The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Res Treat. 2009 May; 115(1):123-9.
View in: PubMed

Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol. 2008 Oct; 19(10):1669-80.
View in: PubMed

Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008 Jun; 8(3):275-80.
View in: PubMed

Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol. 2008 Jun 01; 26(16):2612-3.
View in: PubMed

CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):6542.
View in: PubMed

Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):9571.
View in: PubMed

Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):507.
View in: PubMed

Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008 Feb 20; 26(6):907-12.
View in: PubMed

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20; 100(4):243-51.
View in: PubMed

Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer. 2008 Feb; 8(1):65-9.
View in: PubMed

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008 Feb 01; 26(4):556-62.
View in: PubMed

Care of the Cancer Survivor. Lyman, Supportive Care in Oncology, In Press. 2008.

Reproductive Issues in Breast Cancer Survivors. Diseases of the Breast, In Press. 2008.

Fertility Preservation Considerations in Young Women with Breast Cancer. American Society Of Clinical Oncology Annual Meeting 2008 Educational Book. 2008.

Breast Cancer in Young Women. Diseases of the Breast, In Press. 2008.

Fertility and Adjuvant Treatment in Young Women with Breast Cancer. In Press. 2008.

Fertility Preservation- A Vital Survivorship Issue for Young Women with Breast Cancer. J Clin Oncol, In Press. 2008.

Risk Perceptions and Psychosocial Outcomes of Women with Ductal Carcinoma-in-situ (DCIS): Longitudinal Results from a Cohort Study. J Clin Oncol. 2008; 26(6):907-12.

Fertility. Castiglione M, ed. Adjuvant Therapy for Breast Cancer. 2008.

Perceptions and Management Approaches of Physicians Who Care for Women with Ductal Carcinoma-in-situ (DCIS). J Natl Cancer Inst. 2008; 100(4):243-51.

Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007 Dec; 16 Suppl 2:S175-81.
View in: PubMed

Challenges in the end-of-life care: Commnication about advance directives between patients and providers. Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 269).

Exercise behaviors in a group of women with newly diagnosed ductal carcinoma in situ (DCIS). Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 123).

Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin. 2007 Sep-Oct; 57(5):260-77.
View in: PubMed

Genetic testing in young women with breast cancer: Results from a web-based survey. Proc Am Soc Clin Onc. 2007; (abstr 21093).

Impact of physical activity on insulin levels in breast cancer survivors. Proc Am Soc Clin Oncol. 2007; (abstr 555).

Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007 Jul; 43(11):1646-53.
View in: PubMed

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007 Apr 01; 109(7):1239-46.
View in: PubMed

Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007 Feb 24; 334(7590):407.
View in: PubMed

Adherence with adjuvant hormonal therapy in breast cancer: a report from the Compliance Strategic Intiative Conference. Community Oncology. 2007; 4:1-7.

Oral Chemotherapy safety practices at US cancer centres: questionaire survey. BJM. 2007.

The impact of an exercise invention on body composition, fat distriution, and weight in breast cancer survivors. J Clin Onc. 2007.

Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. Proc Am Soc Clin Oncol. 2006; (abstr 10560).

Lymphopenia in dose-dense chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2093).

The effect of paclitaxel, dose density and trastuzumab on chemotherapy-related amenorrhea (CRA) in premenopausal women with breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2079).

Adherence with adjuvant anastrozole therapy among women with early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 4044).

The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors. Proc Am Soc Clin Onc. 2006; (abstr 590).

Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol. 2006 Nov 20; 24(33):5330-1.
View in: PubMed

An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9.
View in: PubMed

Menopausal-type symptoms in young breast cancer survivors. Ann Oncol. 2006 Dec; 17(12):1777-82.
View in: PubMed

Study participants' perceptions of the process and impact of receiving results of N9831. J Clin Oncol. 2006 Jun 20; 24(18_suppl):518.
View in: PubMed

Combination therapy with gefitinib and capecitabine in metastatic breast cancer (MBC): A phase I trial. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10564.
View in: PubMed

Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10506.
View in: PubMed

Combination therapy with gefitnib and capecitabine in metastatic breast cancer (MBC): A phase I trial. Proc Am Soc Clin Oncol. 2006; (abstr 10564).

Study Participants' perceptions of the process and impact of receiving results N9831. Proc Am Soc Clin Onc. 2006; (abstr 518).

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006 Jun 20; 24(18):2917-31.
View in: PubMed

Non-adherence to endocrine therapy for breast cancer. Ann Oncol. 2006 Feb; 17(2):183-4.
View in: PubMed

Non-adherence to endocrine therapy for breast cancer. Annals of Oncology. 2006; 17:183-84.

American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. J Clin Onc. 2006; 24:2917-31.

Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons. Clin Breast Ca. 2006; 7:158-61.

Contributing author in: Berg WA, Birdwell RL eds. Diagnostic Imaging: Breast. 2006.

Overestimation of risk among women with DCIS: longitudinal results from a cohort study. Breast Cancer Research and Treatment. 2005; (abst 6072).

Standards for follow-up care of patents with breast cancer. Breast. 2005 Dec; 14(6):500-8.
View in: PubMed

Attitudes and management approaches of physicians who care for women with DCIS. Breast Cancer Research and Treatment. 2005; abst 6068.

Premature menopause following chemotherapy for early stage breast cancer: long term results from IBCSG trials V and VI. Breast Cancer Research and Treatment. 2005; (abstr 6055).

Metronomic chemotherapy with and without bevacizumab for advanced breast cancer: a randomized phase II study. Breast Cancer Research and Treatment. 2005; (abst 4).

Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005 Nov 20; 23(33):8340-7.
View in: PubMed

Young women's preferences about adjuvant endocrine therapy for breast cancer. Lancet Oncol. 2005 Aug; 6(8):542-4.
View in: PubMed

Preserving fertility after cancer. CA Cancer J Clin. 2005 Jul-Aug; 55(4):211-28; quiz 263-4.
View in: PubMed

Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V. J Clin Oncol. 2005 Jun; 23(16_suppl):687.
View in: PubMed

Pharmaceutical involvement in breast cancer clinical trials. J Clin Oncol. 2005 Jun; 23(16_suppl):6057.
View in: PubMed

Measuring Decision Quality: Lessons from Pilot Testing. 3rd International Shared Decision Making Conference. 2005.

Shared Decision Making and Posttraumatic Growth in Early-Stage Breast Cancer Survivors. 3rd International Shared Decision Making Conference. 2005.

Delayed premature menopause following chemotherapy for early stage breast cancer: long-term results from IBCSG Trial V. Proc Am Soc Clin Oncol. 2005.

Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park). 2005 May; 19(6):693-7; discussion 697-700.
View in: PubMed

Fertility after breast cancer: questions abound. J Clin Oncol. 2005 Jul 01; 23(19):4259-61.
View in: PubMed

Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005 Mar 12-18; 365(9463):963-4.
View in: PubMed

Ethical and clinical dilemmas resulting from the early closure of recent clinical trials in breast cancer. American Society of Clinical Oncology Annual Meeting, 2005 Educational Book. 2005; 230-41.

Breast Cancer in Young Women. American Society of Clinical Oncology Annual Meeting 2005 Educational Book. 2005; 61-7.

Concerns about fertility after breast cancer in young women. Am J Oncol Rev. 2005; 4:1-3.

Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin in Support of Dose-Dense Adjuvant Chemotherapy. Breast Cancer Research and Treatment. 2004.

Menopausal Symptoms in Very Young Breast Cancer Survivors. Breast Cancer Research and Treatment. 2004.

Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004 Oct 15; 22(20):4174-83.
View in: PubMed

Fertility outcomes in young women with breast cancer: A Web-based survey. J Clin Oncol. 2004 Jul 15; 22(14_suppl):6085.
View in: PubMed

Fertility Outcomes in Young Women with Breast Cancer: A Web-based Survey. Proc Am Soc Clin Oncol. 2004.

Women with Ductal Carcinoma-in-situ Have Inaccurate Risk Perception. Proc Am Soc Clin Oncol. 2004.

Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst. 2004 Apr 21; 96(8):629-32.
View in: PubMed

Long-term complications of adjuvant chemotherapy for early stage breast cancer. Breast Dis. 2004; 21:55-64.
View in: PubMed

Follow-up care of breast cancer survivors. Semin Oncol. 2003 Dec; 30(6):817-25.
View in: PubMed

Breast cancer risk communication: challenges and future research directions: workshop report (United States). Cancer Causes Control. 2003 Apr; 14(3):235-9.
View in: PubMed

Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003 Mar 19; 95(6):491-2.
View in: PubMed

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 Feb 15; 21(4):602-6.
View in: PubMed

Breast cancer risk communication: Challenges abd future directions. Cancer Causes and Control. 2003; 14:235-29.

Geriatric Medicine: An Evidence-Based Approach 4th ed. New York: Springer-Verlag. 2003; 393-416.

Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003; 12(4):280-6.
View in: PubMed

Informing clinical trial participants about study results. JAMA. 2002 Jul 17; 288(3):363-5.
View in: PubMed

Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 01; 94(9):652-61.
View in: PubMed

Treatment of breast cancer during pregnancy. Expert Opin Pharmacother. 2002 Apr; 3(4):423-8.
View in: PubMed

Review of: One Story Two Voices. J Palliative Med. 2002; 5:438-9.

New instruments to measure decision quality for breast cancer. Accepted for the Society for Medical Decision Making 27th Annual Meeting. 2002.

A phase I study of oral cyclophosphamide and UFT + leucovorin (Orzel) in women with advanced breast cancer. Proc Am Soc Clin Oncol. 2001.

Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2001 May 15; 19(10):2722-30.
View in: PubMed

Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. Breast Dis. 2001; 14:41-50.
View in: PubMed

Side effects of chemotherapy and combined chemohormonal therapy in women with early stage breast cancer. J Natl Cancer Institute. 2001; 30:135-42.

Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr. 2001; (30):135-42.
View in: PubMed

Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol. 2000 Dec; 27(6):712-26.
View in: PubMed

Nonmalignant diagnoses in patients. Case 1. Mediastinal lymphadenopathy associated with congestive heart failure. J Clin Oncol. 2000 Jul; 18(13):2635-6.
View in: PubMed

Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years. Clin Breast Cancer. 2000 Jul; 1(2):164-5.
View in: PubMed

Nonmalignant diagnoses in patients. Case 2. Lung cancer with mediastinal lymphadenopathy due to amyloidosis. J Clin Oncol. 2000 Jul; 18(13):2636-7.
View in: PubMed

Letter to the Editor on "Taxanes and Breast Cancer: An Evidence-Based Review of Randomized Phase II and Phase III Trials.". Clin Breast Cancer. 2000; 1:165-65.

Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor. Biol Blood Marrow Transplant. 2000; 6(4A):448-55.
View in: PubMed

The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol. 1999 Jul; 104(1):123-7.
View in: PubMed

Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum. 1997 Dec; 40(12):2199-206.
View in: PubMed

Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum. 1997 Jan; 40(1):57-61.
View in: PubMed

The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 1995 Feb; 38(2):267-73.
View in: PubMed

Evaluation of Social Security disability in claimants with rheumatic disease. Ann Intern Med. 1991 Jul 01; 115(1):26-31.
View in: PubMed

Rehabilitation management of homebound elderly with locomotor disability. Clin Geriatr Med. 1988 May; 4(2):431-9.
View in: PubMed

Evaluation of a rehabilitation component of home care for homebound elderly. Am J Prev Med. 1986 Jan-Feb; 2(1):30-4.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Ratings

Top